nimotuzumab
biocon,oncoscience,daiichi sankyo
['nimotuzumab', 'pancreatic']
survival benefit observed with nimotuzumab plus chemo in kras wild-type advanced pancreatic cancer #asco22 #oncology #pancreaticcancer 
Your online destination for Oncology Nursing news, clinical insights, and resources.